-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Upgrades Editas Medicine to Buy, Announces $8 Price Target

Benzinga·03/10/2026 16:54:17
Listen to the news
Jones Trading analyst Soumit Roy upgrades Editas Medicine (NASDAQ:EDIT) from Hold to Buy and announces $8 price target.